Author:
Shibayama Takuo,Ueoka Hiroshi,Nishii Kenji,Kiura Katsuyuki,Tabata Masahiro,Miyatake Kazuyo,Kitajima Takuji,Harada Mine
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference19 articles.
1. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide;Turrisi;New Engl. J. Med.,1999
2. Final results of a phase III study of concurrent versus sequential radiotherapy (TRT) in combination with cisplatin (P) and etoposide (E) for limited-stage small cell lung cancer (LD-SCLC): The Japan Clinical Oncology Group (JCOG) study;Goto;Proc. ASCO,1999
3. Serum neuron-specific enolase: a marker for disease extent and response to therapy for small-cell lung cancer;Carney;Lancet,1982
4. Serum neuron specific enolase (NSE) levels in patients with non-small-cell lung cancer;Shibayama;Jpn. J. Thoracic Dis.,1992
5. A gastrin-releasing peptide from the porcine non-antral gastric tissue;McDonald;Gut,1978